NYU Langone Health: Clinical Trials & Research Profile

Academic / Institutional Sponsor (Global / Institutional) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationAcademic / Institutional Sponsor (Global / Institutional)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies38 active (23 recruiting now)
Total Tracked Studies (2018 to 2026)86 (7 with California sites)
Completed vs Early-Stopped Studies31 completed / 17 stopped (19.8% stop rate)
Median Closed Enrollment31 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for NYU Langone Health across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk